| abstract |
In order to safely disinfect a human body from Ebola virus, the use of an Ebola virus antibody is thought to be effective. However, mass-producing Ebola virus antibodies requires facilities having high safety standards. The present invention provides a method for producing an Ebola virus antibody characterized by including a step for immunizing a female bird with an Ebola virus recombinant protein as the antigen, and a step for obtaining an antibody from the yolk of an egg laid by the female bird. This method uses a recombinant protein, and as a result, there are no concerns about infection. Consequently, it is possible to produce an antibody in a normal breeding facility, and furthermore, the produced antibody is expected to neutralize Ebola virus. |